VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 174 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $126 | -97.0% | 19 | -97.0% | 0.00% | -100.0% |
| Q1 2023 | $4,251 | +68.2% | 626 | +83.0% | 0.00% | 0.0% |
| Q4 2022 | $2,527 | -15.8% | 342 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $3,000 | – | 342 | +2530.8% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 13 | -95.2% | 0.00% | -100.0% |
| Q4 2021 | $4,000 | +100.0% | 270 | +97.1% | 0.00% | 0.0% |
| Q3 2021 | $2,000 | -33.3% | 137 | -10.5% | 0.00% | 0.0% |
| Q2 2021 | $3,000 | +50.0% | 153 | +11.7% | 0.00% | 0.0% |
| Q1 2021 | $2,000 | 0.0% | 137 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $2,000 | – | 137 | +356.7% | 0.00% | – |
| Q2 2020 | $0 | – | 30 | -11.8% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 34 | -53.4% | 0.00% | – |
| Q4 2019 | $1,000 | 0.0% | 73 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 73 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | 0.0% | 73 | +21.7% | 0.00% | – |
| Q1 2019 | $1,000 | 0.0% | 60 | +36.4% | 0.00% | – |
| Q4 2018 | $1,000 | – | 44 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 2,491,200 | $27,154,000 | 2.37% |
| Profit Investment Management, LLC | 281,890 | $3,071,000 | 2.26% |
| Sio Capital Management, LLC | 488,965 | $5,330,000 | 2.00% |
| Zebra Capital Management LLC | 14,766 | $161,000 | 0.47% |
| Prairiewood Capital, LLC | 50,165 | $547,000 | 0.43% |
| TANG CAPITAL MANAGEMENT LLC | 256,696 | $2,798,000 | 0.42% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $1,700,000 | 0.29% |
| GLOBEFLEX CAPITAL L P | 100,843 | $1,099,000 | 0.27% |
| Epoch Investment Partners, Inc. | 2,757,646 | $30,059,000 | 0.18% |
| EMC Capital Management | 16,185 | $176,000 | 0.15% |